Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #1,701 to #1,750.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Drive from the 1961 Alabama versus Vanderbilt Football Game - 8
  2. Drive from the 1961 Alabama versus Vanderbilt Football Game - 9
  3. Drosten C, et al, N. Engl. J. Med. (2003), cited as Ref 27 in DOI: 10.3390/v12020211
  4. Du F-Y, et al. World J. Stem Cells (2019) cited as Ref 656 in DOI: 10.1038/s41392-020-0110-5
  5. Du Q, et al. Cancer Res. (2009) cited as Ref 402 in DOI: 10.1038/s41392-020-0110-5
  6. Du W, et al. Neuro-Oncology (2015) cited as Ref 272 in DOI: 10.1038/s41392-020-0110-5
  7. Du WQ, et al. J. Cancer Res. Clin. (2009) cited as Ref 696 in DOI: 10.1038/s41392-020-0110-5
  8. Du Y, et al, Am J Respir Crit Care Med (2020), cited as Ref 16 in DOI: 10.1016/j.clim.2020.108427
  9. Du Z, et al. Glia (2009) cited as Ref 75 in DOI: 10.1038/s41392-020-0110-5
  10. Du Z (1st author of DOI /10.3201/eid2605.200146)
  11. Duan S, et al. Nat. Commun. (2015) cited as Ref 359 in DOI: 10.1038/s41392-020-0110-5
  12. Dubé M, et al, J Virol (2018), cited as Ref 69 in DOI: 10.1186/s13054-020-02882-x
  13. Dubrovska A, et al. Proc. Natl Acad. Sci. USA (2009) cited as Ref 370 in DOI: 10.1038/s41392-020-0110-5
  14. Dubé M, et al, J Virol (2018), cited as Ref 69 in DOI: 10.1186/s13054-020-02882-x
  15. Ducre up the middle for 1 to the TU49 (Oden). (10/10/1992)
  16. Ducre up the middle for 2 to the TU32 (Curry). (10/10/1992)
  17. Ducre up the middle for 5 to the TU25 (Hall). (10/10/1992)
  18. Duff SE, et al. FASEB J. (2003) cited as Ref 745 in DOI: 10.1038/s41392-020-0110-5
  19. Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5
  20. Durbin JE (4th author of DOI: 10.1084/jem.20200653)
  21. Ebert K, et al, J. Virol. (2013), cited as Ref 120 in DOI: 10.3390/v12020211
  22. El-Gebali S, et al, Nucleic Acids Res. (2019), cited as Ref 173 in DOI: 10.3390/v12020211
  23. Elbrecht A, et al. Biochem. Biophys. Res. Commun. (1996) cited as Ref 381 in DOI: 10.1038/s41392-020-0110-5
  24. Eli Stove run for 1 yd to the Aub 38 (11/25/17)
  25. Eli Stove run for 7 yds to the Alab 3 (11/25/17)
  26. Elie M, et al, CMAJ (2000), cited as Ref 10 in DOI: 10.1186/s13054-020-02882-x
  27. Ellwood-Yen K, et al. Cancer Cell (2003) cited as Ref 120 in DOI: 10.1038/s41392-020-0110-5
  28. Ely EW, et al, Crit Care Med (2001), cited as Ref 29 in DOI: 10.1186/s13054-020-02882-x
  29. Ely EW, et al, Crit Care Med (2017), cited as Ref 38 in DOI: 10.1186/s13054-020-02882-x
  30. Ely EW, et al, Intensive Care Med (2001), cited as Ref 70 in DOI: 10.1186/s13054-020-02882-x
  31. Ely EW, et al, JAMA (2004), cited as Ref 71 in DOI: 10.1186/s13054-020-02882-x
  32. Ely EW, et al, Jama (2001), cited as Ref 22 in DOI: 10.1186/s13054-020-02882-x
  33. Ely EW (6th author of DOI: 10.1186/s13054-020-02882-x)
  34. Emanuel EJ, et al, N Engl J Med (2020), cited as Ref 34 in DOI: 10.1186/s13054-020-02882-x
  35. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148)
  36. End Period
  37. End of 1st Quarter
  38. End of 1st Quarter (1/1/18)
  39. End of 1st Quarter (1/8/18)
  40. End of 1st Quarter (10-14-17)
  41. End of 1st Quarter (10-21-17)
  42. End of 1st Quarter (10-7-17)
  43. End of 1st Quarter (11/11/17)
  44. End of 1st Quarter (11/18/17)
  45. End of 1st Quarter (11/25/17)
  46. End of 1st Quarter (11/4/17)
  47. End of 1st Quarter (9-30-17)
  48. End of 1st Quarter (9/16/17)
  49. End of 1st Quarter (9/2/17)
  50. End of 1st Quarter (9/23/17)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)